{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:45:25Z","timestamp":1785894325171,"version":"3.56.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.7759\/cureus.113961","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:56:07Z","timestamp":1785891367000},"source":"Crossref","is-referenced-by-count":0,"title":["Left-Sided Pseudomonas Infective Endocarditis Presenting with Septic Shock and Ischemic Stroke in a Non-Injection Drug User Receiving PD-L1 Inhibitor Therapy"],"prefix":"10.7759","author":[{"given":"Gilgamish","family":"Maloul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnav K","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelish","family":"Ardeshna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Swearingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032662","article-title":"A contemporary case series of Pseudomonas aeruginosa infective endocarditis","volume":"102","author":"Walczak A","year":"2023","unstructured":"Walczak A, McCarthy K, Paterson DL. A contemporary case series of Pseudomonas aeruginosa infective endocarditis. Medicine (Baltimore). 2023, 102:e32662. 10.1097\/MD.0000000000032662","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae205","article-title":"Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis","volume":"79","author":"Shah S","year":"2024","unstructured":"Shah S, Clarke L, Davis MW, Topal JE, Shields RK. Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis. J Antimicrob Chemother. 2024, 79:2017-21. 10.1093\/jac\/dkae205","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e14613","article-title":"Updated estimates of eligibility and response: immune checkpoint inhibitors","volume":"42","author":"Prasad V","year":"2024","unstructured":"Prasad V, Haslam A, Olivier T. Updated estimates of eligibility and response: immune checkpoint inhibitors. J Clin Oncol. 2024, 42:14613. 10.1200\/JCO.2024.42.16_suppl.e14613","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217260","article-title":"Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy","volume":"77","author":"Morelli T","year":"2022","unstructured":"Morelli T, Fujita K, Redelman-Sidi G, Elkington PT. Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. Thorax. 2022, 77:304-11. 10.1136\/thoraxjnl-2021-217260","journal-title":"Thorax"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182252133","article-title":"Left-sided Pseudomonas aeruginosa endocarditis in patients without injection drug use","volume":"90","author":"Dawson NL","year":"2011","unstructured":"Dawson NL, Brumble LM, Pritt BS, Yao JD, Echols JD, Alvarez S. Left-sided Pseudomonas aeruginosa endocarditis in patients without injection drug use. Medicine (Baltimore). 2011, 90:250-5. 10.1097\/MD.0b013e3182252133","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02208-17","article-title":"Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort","volume":"62","author":"Falcone M","year":"2018","unstructured":"Falcone M, Tiseo G, Durante-Mangoni E, et al.. Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort. Antimicrob Agents Chemother. 2018, 62:10.1128\/AAC.02208-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2014.08.019","article-title":"Pseudomonas aeruginosa infective endocarditis in patients who do not use intravenous drugs: analysis of risk factors and treatment outcomes","volume":"49","author":"Lin TI","year":"2016","unstructured":"Lin TI, Huang YF, Liu PY, et al.. Pseudomonas aeruginosa infective endocarditis in patients who do not use intravenous drugs: analysis of risk factors and treatment outcomes. J Microbiol Immunol Infect. 2016, 49:516-22. 10.1016\/j.jmii.2014.08.019","journal-title":"J Microbiol Immunol Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198605000-00006","article-title":"Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature","volume":"65","author":"Wieland M","year":"1986","unstructured":"Wieland M, Lederman MM, Kline-King C, et al.. Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature. Medicine (Baltimore). 1986, 65:180-9. 10.1097\/00005792-198605000-00006","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.03.148","article-title":"A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE","volume":"241","author":"Di Mauro M","year":"2017","unstructured":"Di Mauro M, Dato GM, Barili F, et al.. A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE. Int J Cardiol. 2017, 241:97-102. 10.1016\/j.ijcard.2017.03.148","journal-title":"Int J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.066","article-title":"Challenges in infective endocarditis","volume":"69","author":"Cahill TJ","year":"2017","unstructured":"Cahill TJ, Baddour LM, Habib G, et al.. Challenges in infective endocarditis. J Am Coll Cardiol. 2017, 69:325-44. 10.1016\/j.jacc.2016.10.066","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.09.025","article-title":"Infectious complications in patients treated with immune checkpoint inhibitors","volume":"141","author":"Karam JD","year":"2020","unstructured":"Karam JD, Noel N, Voisin AL, Lanoy E, Michot JM, Lambotte O. Infectious complications in patients treated with immune checkpoint inhibitors. Eur J Cancer. 2020, 141:137-42. 10.1016\/j.ejca.2020.09.025","journal-title":"Eur J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506942-left-sided-pseudomonas-infective-endocarditis-presenting-with-septic-shock-and-ischemic-stroke-in-a-non-injection-drug-user-receiving-pd-l1-inhibitor-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:56:08Z","timestamp":1785891368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506942-left-sided-pseudomonas-infective-endocarditis-presenting-with-septic-shock-and-ischemic-stroke-in-a-non-injection-drug-user-receiving-pd-l1-inhibitor-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.113961","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}